OTLK Surges 43.6% on FDA News; WDC +41%, FCEL +37.5% Lead EPS Revision Movers
Outlook Therapeutics (OTLK) jumped 43.6% after an upward EPS revision (48.3%→53.0%) was reinforced by FDA acceptance of its BLA for wet AMD. Western Digital (WDC) gained 41.0% on a 76.4% EPS growth estimate and blockbuster earnings driven by AI/cloud demand. FuelCell Energy (FCEL), Ultra Clean Holdings (UCTT), and Robinhood (HOOD) also rallied after analysts raised estimates, with HOOD supported by record trading volumes and analyst upgrades.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| OTLK | Healthcare | 2026-06-11 | +4.8pp | +43.6% |
| WDC | Technology | 2026-06-11 | N/A | +41.0% |
| FCEL | Industrials | 2026-06-09 | N/A | +37.5% |
| UCTT | Technology | 2026-06-09 | +3.5pp | +32.0% |
| HOOD | Financial | 2026-06-09 | N/A | +29.1% |
Why did OTLK stock jump in June 2026?
OTLK jumped 43.6% from $1.10 to $1.58 after analysts raised its forward EPS growth estimate from 48.3% to 53.0% on June 11.
The move accelerated on June 16 when the FDA accepted Outlook Therapeutics' resubmitted BLA for ONS-5010/LYTENAVA, setting a PDUFA date of July 29, 2026. The resubmission marked a key milestone toward becoming the first FDA-approved ophthalmic bevacizumab formulation.
OTLK EPS revision history → · Screener snapshot from 2026-06-11 →
FAQ: OTLK
Why did OTLK stock jump?
OTLK jumped 43.6% between June 11 and June 18 after analysts raised its forward EPS growth estimate from 48.3% to 53.0% and the FDA accepted its BLA resubmission for wet AMD.
Is OTLK a buy after the rally?
The rally is tied to a specific catalyst — FDA acceptance with a July 29 PDUFA date — and the EPS revision suggests improving profitability expectations, but investors should weigh the binary risk of approval.
What is OTLK's EPS growth estimate?
As of June 11, OTLK's forward EPS growth estimate was raised to 53.0%, up from 48.3% before the revision.
Why did WDC stock jump in June 2026?
WDC jumped 41.0% from $529.29 to $746.23 after analysts raised its forward EPS growth estimate to 76.4% on June 11.
The rally was confirmed on June 17 when Western Digital reported fiscal Q3 2026 earnings nearly doubling to $2.72 per share alongside $3.3 billion in revenue (+45% YoY) and issued strong guidance. Institutional demand and a broader rotation into cyclical tech names further supported the move.
WDC EPS revision history → · Screener snapshot from 2026-06-11 →
FAQ: WDC
Why did WDC stock surge?
WDC surged 41.0% after analysts raised its forward EPS growth estimate to 76.4% and the company reported earnings nearly doubled on AI and cloud demand, with revenue up 45% YoY.
Is WDC a buy after the rally?
With EPS expected to grow 76.4% next year and strong institutional inflows, WDC's fundamental trajectory supports the move, though the stock is up 295% YTD.
What caused WDC's EPS revision?
Analysts revised WDC's EPS growth estimate higher after its Q3 earnings showed a 50.7% sales growth rate and 17% profit margin, driven by hyperscaler demand for data storage.
Why did FCEL stock jump in June 2026?
FCEL jumped 37.5% from $17.49 to $24.04 after analysts raised its forward EPS growth estimate to 40.8% on June 9.
No company-specific news emerged, but the move tracked a broader rotation into industrials and clean energy stocks amid easing geopolitical tensions, as the Iran deal lowered energy costs and boosted cyclical sentiment.
FCEL EPS revision history → · Screener snapshot from 2026-06-09 →
FAQ: FCEL
Why did FCEL stock jump?
FCEL jumped 37.5% after analysts raised its forward EPS growth estimate to 40.8% on June 9, with gains amplified by a sector rotation into industrials and clean energy following easing geopolitical risks.
What is FCEL's EPS growth estimate?
FCEL's forward EPS growth estimate stands at 40.8%, reflecting improved analyst expectations for the fuel cell company.
What caused FCEL's surge?
The surge was driven by an upward EPS revision and a macro shift toward economically sensitive and clean-energy stocks after the U.S.-Iran peace deal.
Why did UCTT stock jump in June 2026?
UCTT jumped 32.0% from $91.88 to $121.28 after analysts raised its forward EPS growth estimate from 83.2% to 86.8% on June 9.
The semiconductor equipment maker benefited from rising demand for chip manufacturing tools, with no specific news but strong sector tailwinds as AI and cloud spending drove capex increases across the industry.
UCTT EPS revision history → · Screener snapshot from 2026-06-09 →
FAQ: UCTT
Why did UCTT stock jump?
UCTT jumped 32.0% after analysts raised its forward EPS growth estimate from 83.2% to 86.8% on June 9, driven by strong semiconductor equipment demand.
Is UCTT a buy after the rally?
With EPS growth expected near 87% next year and the semiconductor cycle still expanding, UCTT's upward revision suggests continued momentum.
What is UCTT's EPS growth estimate?
UCTT's forward EPS growth estimate was raised to 86.8% on June 9, up from 83.2% prior to the revision.
Why did HOOD stock jump in June 2026?
HOOD jumped 29.1% from $83.77 to $108.15 after analysts raised its forward EPS growth estimate to 37.4% on June 9.
The rally was reinforced by Deutsche Bank and Argus raising price targets to $105 and $110, respectively, citing record June trading volumes and prediction markets revenue expected to surge to $600 million in 2026 from $150 million. A 10% headcount reduction was framed as proactive streamlining.
HOOD EPS revision history → · Screener snapshot from 2026-06-09 →
FAQ: HOOD
Why did HOOD stock jump?
HOOD jumped 29.1% after analysts raised its forward EPS growth estimate to 37.4% on June 9, followed by price target upgrades and record trading volumes in June.
Is HOOD a buy after the rally?
Analysts see continued high growth from brokerage expansion and prediction markets, with Argus setting a $110 target and Deutsche Bank at $105, both maintaining Buy.
What caused HOOD's surge?
The surge was driven by an upward EPS revision, analyst upgrades citing record trading activity, and expectations that prediction markets revenue will nearly quadruple in 2026.
Today's top performers underscore how early detection of upward EPS revisions can capture significant price appreciation, especially when followed by confirming news or sector catalysts. The mix of biotech, tech, clean energy, and financials suggests broad-based optimism driven by AI demand, easing geopolitical risks, and improving earnings visibility.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →